It was announced today that ZonMw expects to launch a new call for proposals in September under the PharmaNL Shared Development Infrastructure (SDI) programme line.
PharmaNL’s ‘Shared Development Infrastructure’ programme line focuses on establishing or expanding infrastructure for the development, scale-up, and production of innovative medicines in the Netherlands. Keep an eye on the ZonMw and PharmaNL websites for the exact opening date.
Projects must align with the priority themes outlined in PharmaNL’s revised 2026 investment agenda.
The PharmaNL programme is an initiative by and for the Dutch pharmaceutical sector. It is a national public-private consortium comprising Leiden University, Campus Groningen, and Pivot Park, working in close collaboration with FAST (Centre for Future Affordable Sustainable Therapy Development). PharmaNL aims to strengthen the pharmaceutical value chain in the Netherlands and remove bottlenecks.
PharmaNL is made possible through investments from its partners and an award from the National Growth Fund.
